A study to investigate safety, tolerability, and pharmacokinetics of oral AZD0233 compared with placebo in healthy adult participants.

Trial Identifier:	D7250C00001
Sponsor:	AstraZeneca
Collaborator:	Parexel
NCTID::	NCT06381466
Start Date:	April 2024
Primary Completion Date:	March 2025
Study Completion Date:	March 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, CA	Glendale, CA, US, 91206

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.